Advertisement
Advertisement

VIGL

VIGL logo

Vigil Neuroscience, Inc. Common Stock

1.73
USD
+0.22
+14.24%
Apr 17, 15:55 UTC -4
Closed
exchange

After-Market

1.73

0.00
0.00%

Vigil Neuroscience, Inc. Common Stock Profile

About

Vigil Neuroscience Inc. is a microglia-focused therapeutics company. It focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Vigil Neuroscience Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Ivana Magovcevic-Liebisch

Headquarters

100 FORGE ROAD, SUITE 700
WATERTOWN, MA 02472, UNITED STATES

Sector

Medical

Auditor

PricewaterhouseCoopers LLP

Share holders

6

Employees

89

Vigil Neuroscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

80.51M

Enterprise Value

41.49M

Enterprise Value/EBITDA(ttm)

-0.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-83.89%

Return on Invested Capital(ttm)

-99.12%

Return on Assets(ttm)

-65.34%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-90.78M

Net Income Available to Common(ttm)

-84.26M

Diluted EPS(ttm)

-2.06

Share Statistics

Beta (5Y Monthly)

1.84

52-Week Change

-37.27%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

46.67M

Dividend Yield

0.00%

Float4

27.38M

% Held by Insiders

33.03%

% Held by Institutions

83.64%

Balance Sheet

Total Cash(mrq)

97.80M

Total Cash Per Share(mrq)

2.10

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.95%

Quick Ratio(mrq)

3.72%

Book Value Per Share(mrq)

1.75

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.26

Free Cash Flow(ytd)

-51.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement